AWAK Attracts Investment Billions

Singapore-based AWAK Technologies’ miniaturized sorbent platform for PD and HD regenerates dialysate to use up to 90% less fluid. This package was intriguing enough to attract an $11.2B investment from Accuron MedTech—improving its changes of reaching the market!

Read the full article » | Posted 06-12-2017

Gel Increases Success Rate of AVF Development Posted 01-14-2022
Alio and Lifeline Partner for Dialysis Access Patient Monitoring Posted 12-16-2021
Patient Needs Should Drive Kidney Innovation Posted 12-16-2021
PeritoneX Internally Disinfects PD Catheters Posted 11-12-2021

AWAK Attracts Investment Billions

Related Articles

Champion Sponsors

Partner Sponsors